Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion evidence source_evidence_literature NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion SIO_000772 23110939 NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion wasDerivedFrom befree-2016 NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_assertion wasGeneratedBy ECO_0000203 NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1024928.RAdtq5KkOXS-BUDgj__ScuL4nIHfVCl7Mqd8eDgdVp9lc130_provenance.